Health Insurance & Protection is part of the Business Intelligence Division of Informa PLC

Informa PLC | About us | Investor relations | Talent

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Gene therapy medication top innovation desired by Brits

But most still want human involvement in healthcare

Gene therapy medication to help prevent dementia or cancer is the top future technology innovation desired by Brits, cited by 68% of respondents to a Bupa survey.

Second on the list was a home hospital diagnostics machine that conducts scans and blood tests at home, chosen by 62% of respondents.

This was followed by a full report on your DNA that tells you your risk of being affected by certain diseases like cancer (62%), a geolocation app to alert you where not to go to avoid catching a disease like flu or where air quality might make you unwell (55%), and a computer packed with medical knowledge that would help diagnose health issues (54%). 

However, although a range of future technologies were welcomed, 78% stated that human involvement was still the most important factor when it comes to healthcare, and a similar number (76%) claimed to be comfortable with using health technology as long as there is a human involved at some stage.

Dr. Søren Carstens, head of clinical operations at Bupa Global, said tech can enable us to know, diagnose and understand more of what is happening in our bodies, but that knowledge must be interpreted by a trained eye to be useful and safe. The report also found more than eight in 10 people believe it is a major priority to improve the quality of information available by removing fake and inaccurate advice from the internet.

Nearly three quarters (73%) went a step further, suggesting a formal accreditation should be put in place for online heath advice.